Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

2011/06/14 by Roland R. Griffiths, Matthew W. Johnson, William A. Richards +5 · 29 citations
Psychology · Pharmacology, Toxicology and Pharmaceutics · #Psychedelics and Drug Studies #Forensic Toxicology and Drug Analysis #Paranormal Experiences and Beliefs

paper · doi:10.1007/s00213-011-2358-5

Citations

• Dose-Response Study of N,N-Dimethyltryptamine in Humans
• Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study
• Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
• Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

Cited by

• Mushroom poisoning: A proposed new clinical classification
• Dissolving yourself in connection to others: shared experiences of ego attenuation and connectedness during group VR experiences can be comparable to psychedelics
• Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
• People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences
• Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models
• Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms
• A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience
• Understanding mystical experiences through the lens of entropy: introduction to the special issue on ‘mystical entropy’
• Therapeutic use of psilocybin: Practical considerations for dosing and administration
• Psychedelic microdosing benefits and challenges: an empirical codebook
• Behavioural investigations of psilocybin in non-human animals 1962–2021: A scoping review
• A qualitative analysis of the psychedelic mushroom come-up and come-down
• Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
• Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
• Psychedelics beyond medicine: Treatment, enhancement, hype, consent, and the limits of medicalization
• From flow to mystical experiences: Connecting entropy and fluency along the unifying framework of cognitive continuum
• Predictors and potentiators of psychedelic-occasioned mystical experiences
• Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives
• Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions
• The science of psychedelic medicine
• Psychedelics and the future evolution of humanity
• Prediction of hallucinogen persisting perception disorder and thought disturbance symptoms following psychedelic use
• Peak Experiences Matter
• Psychedelics and environmental virtues
• Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness
• Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities
• Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts
• Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
• Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study